Along with the dramatic increase in opioid related deaths, much data called into question the long term safety and efficacy of opioids. Based on this information, the Centers for Disease Control (CDC) issued guidelines for the prescribing of opioids for chronic pain in 2016. The CDC stated that the guidelines were intended to help providers make safer and more effective decisions, improve functional status of patients, and reduce adverse effects. The guidelines were intended for the management of non-cancer pain, and not pain associated with active cancer, palliative care, or end-of-life care.
Learning Level: 2
Activity Type: Application-based
Target Audience: Pharmacists
At the completion of this application-based activity, participants will be able to:
- Describe the approach to chronic pain management outlined in the CDC Guideline for Prescribing Opioids for Chronic Pain
- Identify the approach to acute pain management outlined in the CDC Guideline for Prescribing Opioids for Chronic Pain
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is approved for 1 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-222-H01-P.
To obtain credit for completing A Review of CDC Guidelines for Prescribing Opioids for Chronic Pain, complete the learning activity, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: July 15, 2019
Expiration date: July 15, 2022
A Review of CDC Guidelines for Prescribing Opioids for Chronic Pain is an online educational activity for pharmacists developed by the American Pharmacists Association.
APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
There is no fee associated with this activity.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.